Nonetheless, we acknowledge substantial differences in methodology and population characteristics, including the unique RCT design of our study involving women with obesity, the comprehensive adjustment for confounders in our models, and the earlier timing of fasting insulin measurements. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.